QQQ   437.14 (+0.43%)
AAPL   180.75 (-0.37%)
MSFT   407.88 (+0.04%)
META   487.80 (+0.78%)
GOOGL   137.06 (+0.50%)
AMZN   174.65 (+0.86%)
TSLA   199.87 (-1.07%)
NVDA   791.14 (+1.87%)
NIO   5.64 (+3.87%)
AMD   186.56 (+5.68%)
BABA   74.20 (-0.52%)
T   17.00 (+0.24%)
F   12.43 (+1.06%)
MU   89.53 (-0.20%)
CGC   3.32 (-1.19%)
GE   156.12 (+0.33%)
DIS   111.32 (+0.47%)
AMC   4.43 (-11.22%)
PFE   26.89 (-0.55%)
PYPL   60.71 (+0.76%)
XOM   104.75 (+0.41%)
QQQ   437.14 (+0.43%)
AAPL   180.75 (-0.37%)
MSFT   407.88 (+0.04%)
META   487.80 (+0.78%)
GOOGL   137.06 (+0.50%)
AMZN   174.65 (+0.86%)
TSLA   199.87 (-1.07%)
NVDA   791.14 (+1.87%)
NIO   5.64 (+3.87%)
AMD   186.56 (+5.68%)
BABA   74.20 (-0.52%)
T   17.00 (+0.24%)
F   12.43 (+1.06%)
MU   89.53 (-0.20%)
CGC   3.32 (-1.19%)
GE   156.12 (+0.33%)
DIS   111.32 (+0.47%)
AMC   4.43 (-11.22%)
PFE   26.89 (-0.55%)
PYPL   60.71 (+0.76%)
XOM   104.75 (+0.41%)
QQQ   437.14 (+0.43%)
AAPL   180.75 (-0.37%)
MSFT   407.88 (+0.04%)
META   487.80 (+0.78%)
GOOGL   137.06 (+0.50%)
AMZN   174.65 (+0.86%)
TSLA   199.87 (-1.07%)
NVDA   791.14 (+1.87%)
NIO   5.64 (+3.87%)
AMD   186.56 (+5.68%)
BABA   74.20 (-0.52%)
T   17.00 (+0.24%)
F   12.43 (+1.06%)
MU   89.53 (-0.20%)
CGC   3.32 (-1.19%)
GE   156.12 (+0.33%)
DIS   111.32 (+0.47%)
AMC   4.43 (-11.22%)
PFE   26.89 (-0.55%)
PYPL   60.71 (+0.76%)
XOM   104.75 (+0.41%)
QQQ   437.14 (+0.43%)
AAPL   180.75 (-0.37%)
MSFT   407.88 (+0.04%)
META   487.80 (+0.78%)
GOOGL   137.06 (+0.50%)
AMZN   174.65 (+0.86%)
TSLA   199.87 (-1.07%)
NVDA   791.14 (+1.87%)
NIO   5.64 (+3.87%)
AMD   186.56 (+5.68%)
BABA   74.20 (-0.52%)
T   17.00 (+0.24%)
F   12.43 (+1.06%)
MU   89.53 (-0.20%)
CGC   3.32 (-1.19%)
GE   156.12 (+0.33%)
DIS   111.32 (+0.47%)
AMC   4.43 (-11.22%)
PFE   26.89 (-0.55%)
PYPL   60.71 (+0.76%)
XOM   104.75 (+0.41%)

Dyne Therapeutics (DYN) News Today

$26.31
+1.33 (+5.32%)
(As of 11:04 AM ET)
SourceHeadline
marketbeat.com logoDyne Therapeutics, Inc. (NASDAQ:DYN) Shares Sold by Algert Global LLC
marketbeat.com - February 27 at 6:54 AM
MarketBeat logoDyne Therapeutics, Inc. (NASDAQ:DYN) Director Sells $2,704,697.60 in Stock
americanbankingnews.com - February 26 at 5:44 AM
MarketBeat logoInsider Selling: Dyne Therapeutics, Inc. (NASDAQ:DYN) Major Shareholder Sells $3,621,603.40 in Stock
americanbankingnews.com - February 26 at 4:58 AM
MarketBeat logoInsider Selling: Dyne Therapeutics, Inc. (NASDAQ:DYN) Major Shareholder Sells $4,164,187.57 in Stock
americanbankingnews.com - February 26 at 4:18 AM
uk.finance.yahoo.com logoDYN Mar 2024 20.000 call
uk.finance.yahoo.com - February 24 at 7:30 AM
marketbeat.com logoRafferty Asset Management LLC Has $1.25 Million Stock Position in Dyne Therapeutics, Inc. (NASDAQ:DYN)
marketbeat.com - February 24 at 5:34 AM
marketbeat.com logoDyne Therapeutics, Inc. (NASDAQ:DYN) Director Jason P. Rhodes Sells 119,360 Shares
marketbeat.com - February 23 at 9:27 PM
MarketBeat logoDyne Therapeutics, Inc. (NASDAQ:DYN) Forecasted to Post FY2023 Earnings of ($3.92) Per Share
americanbankingnews.com - February 23 at 1:24 AM
marketbeat.com logoDyne Therapeutics, Inc. (NASDAQ:DYN) Expected to Earn FY2023 Earnings of ($3.92) Per Share
marketbeat.com - February 22 at 6:50 AM
seekingalpha.com logoDyne Therapeutics: An Updated Analysis
seekingalpha.com - February 21 at 2:49 PM
msn.com logoHC Wainwright & Co. Initiates Coverage of Dyne Therapeutics (DYN) with Buy Recommendation
msn.com - February 21 at 9:59 AM
MarketBeat logoDyne Therapeutics, Inc. (NASDAQ:DYN) Major Shareholder Venture Fund Xi L.P. Atlas Sells 162,707 Shares
americanbankingnews.com - February 21 at 5:04 AM
MarketBeat logoDyne Therapeutics, Inc. (NASDAQ:DYN) Director Jason P. Rhodes Sells 169,539 Shares of Stock
americanbankingnews.com - February 21 at 4:20 AM
MarketBeat logoDyne Therapeutics, Inc. (NASDAQ:DYN) Director Jason P. Rhodes Sells 177,906 Shares of Stock
americanbankingnews.com - February 21 at 4:20 AM
MarketBeat logoDyne Therapeutics (NASDAQ:DYN) Receives New Coverage from Analysts at HC Wainwright
americanbankingnews.com - February 21 at 3:44 AM
marketbeat.com logoDyne Therapeutics (NASDAQ:DYN) Shares Gap Up to $22.91
marketbeat.com - February 20 at 10:59 AM
marketbeat.com logoHC Wainwright Begins Coverage on Dyne Therapeutics (NASDAQ:DYN)
marketbeat.com - February 20 at 7:24 AM
finance.yahoo.com logoDYN Mar 2024 10.000 call
finance.yahoo.com - February 19 at 9:23 AM
ca.finance.yahoo.com logoDYN Mar 2024 20.000 put
ca.finance.yahoo.com - February 17 at 8:44 PM
ca.finance.yahoo.com logoDYN Mar 2024 22.500 put
ca.finance.yahoo.com - February 17 at 3:00 PM
finance.yahoo.com logoDYN Mar 2024 30.000 call
finance.yahoo.com - February 17 at 9:59 AM
finance.yahoo.com logoDYN Mar 2024 25.000 put
finance.yahoo.com - February 17 at 9:59 AM
investing.com logoDyne Therapeutics Inc (DYN)
investing.com - February 16 at 3:14 AM
finance.yahoo.com logoDyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference
finance.yahoo.com - February 14 at 8:53 PM
globenewswire.com logoDyne Therapeutics Announces Upcoming Presentations on Initial Clinical Data From its ACHIEVE Trial in DM1 Patients and DELIVER Trial in DMD Patients at the 2024 Muscular Dystrophy Association Clinical & Scientific Conference
globenewswire.com - February 14 at 4:15 PM
marketbeat.com logoDyne Therapeutics (NASDAQ:DYN) Shares Gap Down to $24.01
marketbeat.com - February 12 at 11:45 AM
markets.businessinsider.com logoStifel Nicolaus Reaffirms Their Buy Rating on Dyne Therapeutics (DYN)
markets.businessinsider.com - February 10 at 5:06 AM
marketbeat.com logoDyne Therapeutics (NASDAQ:DYN) Trading Up 7.8%
marketbeat.com - February 9 at 3:02 PM
benzinga.com logoDyne Therapeutics Stock (NASDAQ:DYN) Insider Trades
benzinga.com - February 7 at 7:28 PM
benzinga.com logoDyne Therapeutics Stock (NASDAQ:DYN), Short Interest Report
benzinga.com - February 7 at 9:27 AM
marketbeat.com logoVivo Capital LLC Grows Stock Holdings in Dyne Therapeutics, Inc. (NASDAQ:DYN)
marketbeat.com - February 6 at 1:40 PM
finance.yahoo.com logoDyne Therapeutics to Present at February Investor Conferences
finance.yahoo.com - February 1 at 8:57 AM
marketbeat.com logoAssenagon Asset Management S.A. Has $6.46 Million Position in Dyne Therapeutics, Inc. (NASDAQ:DYN)
marketbeat.com - January 30 at 6:21 AM
finance.yahoo.com logoChief Business Officer Jonathan Mcneill Sells 20,000 Shares of Dyne Therapeutics Inc (DYN)
finance.yahoo.com - January 26 at 11:28 PM
marketbeat.com logo
marketbeat.com - January 26 at 2:45 PM
finance.yahoo.com logoInstitutional owners may ignore Dyne Therapeutics, Inc.'s (NASDAQ:DYN) recent US$56m market cap decline as longer-term profits stay in the green
finance.yahoo.com - January 14 at 9:20 AM
marketbeat.com logoDyne Therapeutics (NASDAQ:DYN) Shares Gap Up After Insider Buying Activity
marketbeat.com - January 12 at 10:28 AM
finance.yahoo.com logoDyne Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters of Option to Purchase Additional Shares
finance.yahoo.com - January 11 at 6:33 PM
marketbeat.com logoDyne Therapeutics, Inc. (NASDAQ:DYN) Director Acquires $29,999,987.50 in Stock
marketbeat.com - January 11 at 6:32 PM
marketbeat.com logoDyne Therapeutics, Inc. (NYSE:DYN) Given Average Rating of "Buy" by Analysts
marketbeat.com - January 7 at 4:20 AM
nasdaq.com logoDyne Therapeutics Prices Public Offering Of 17.15 Mln Shares At $17.50/shr; Stock Surges
nasdaq.com - January 5 at 12:40 PM
finance.yahoo.com logoCEO & President Joshua Brumm Sells 269,719 Shares of Dyne Therapeutics Inc (DYN)
finance.yahoo.com - January 5 at 12:40 PM
marketbeat.com logoDyne Therapeutics (NYSE:DYN) Trading Down 9.1% After Insider Selling
marketbeat.com - January 5 at 10:10 AM
finance.yahoo.com logoDyne Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 5 at 7:41 AM
msn.com logoDyne Therapeutics prices stock offering to raise $300.1 million
msn.com - January 5 at 1:58 AM
benzinga.com logoDyne Therapeutics Stock (NASDAQ:DYN) Dividends: History, Yield and Dates
benzinga.com - January 5 at 1:00 AM
finance.yahoo.com logoDyne Therapeutics Announces Pricing of $300 Million Public Offering of Common Stock
finance.yahoo.com - January 5 at 1:00 AM
marketbeat.com logoDyne Therapeutics, Inc. (NYSE:DYN) SVP Richard William Scalzo Sells 13,000 Shares
marketbeat.com - January 5 at 12:42 AM
msn.com logoThese Stocks Are Moving the Most Today: Meta, Cal-Maine Foods, Dyne Therapeutics, Intel, Micron, Walgreens, and More
msn.com - January 4 at 9:49 AM
seekingalpha.com logoAssessing Dyne Therapeutics' Muscular Dystrophy Data: Early Promise, Caution Needed
seekingalpha.com - January 4 at 7:30 AM
Get Dyne Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DYN and its competitors with MarketBeat's FREE daily newsletter.



DYN Media Mentions By Week

DYN Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DYN
News Sentiment

0.37

0.63

Average
Medical
News Sentiment

DYN News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DYN Articles
This Week

19

2

DYN Articles
Average Week

Get Dyne Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for DYN and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:DYN) was last updated on 2/29/2024 by MarketBeat.com Staff